Critical Comparison: Envoy Medical (NASDAQ:COCH) vs. TearLab (OTCMKTS:TEAR)

TearLab (OTCMKTS:TEAR) and Envoy Medical (NASDAQ:COCH) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Earnings & Valuation

This table compares TearLab and Envoy Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TearLab	N/A	N/A	N/A	N/A	N/A
Envoy Medical	$220,000.00	90.15	-$20.80 million	($1.41)	-0.49

TearLab has higher earnings, but lower revenue than Envoy Medical.

Profitability

This table compares TearLab and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TearLab	N/A	N/A	N/A
Envoy Medical	-11,950.00%	N/A	-248.54%

Institutional & Insider Ownership

8.6% of Envoy Medical shares are owned by institutional investors. 5.2% of TearLab shares are owned by company insiders. Comparatively, 5.7% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and price targets for TearLab and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TearLab	0	0	0	0	0.00
Envoy Medical	1	0	1	0	2.00

Envoy Medical has a consensus price target of $9.50, indicating a potential upside of 1,279.01%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than TearLab.

Summary

Envoy Medical beats TearLab on 6 of the 8 factors compared between the two stocks.

About TearLab

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.